Tempest Therapeutics, Inc. (TPST)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-393.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $295.0K | $653.0K |
| Cost of Revenue | — | — | — | — | — | — | — | — | $790.0K | $5.40M |
| Operating Income | -$26.57M | -$42.03M | -$29.16M | -$34.64M | -$26.99M | -$19.30M | -$45.40M | -$26.87M | -$84.33M | -$81.01M |
| Net Income | -$26.26M | -$41.84M | -$29.49M | -$35.71M | -$28.30M | -$19.21M | -$44.57M | -$27.19M | -$84.58M | -$82.26M |
| EPS (Diluted) | $-6.33 | $-19.50 | $-1.91 | $-3.09 | $-7.47 | $-41.03 | — | — | — | — |
| Total Assets | $16.93M | $41.49M | $51.60M | $46.09M | $73.24M | $22.86M | $74.97M | $84.07M | $19.81M | $122.54M |
| Total Liabilities | $10.26M | $22.36M | $24.84M | $27.98M | $37.12M | $4.95M | $15.10M | $10.95M | $4.83M | $14.32M |
| Shareholders' Equity | $6.67M | $19.13M | $26.77M | $18.11M | $36.12M | -$68.79M | -$50.36M | $70.95M | -$130.69M | $108.22M |
| Cash & Equivalents | $7.71M | $30.27M | $39.23M | $31.23M | $51.83M | $18.82M | $62.48M | $73.29M | $17.58M | $43.93M |
| Operating Cash Flow | -$26.82M | -$33.03M | -$27.36M | -$31.07M | -$25.96M | -$19.02M | -$41.22M | -$23.65M | -$20.34M | -$61.73M |
| Capital Expenditures | $0 | $435.0K | $170.0K | $562.0K | $135.0K | $50.0K | $397.0K | $36.0K | $4.0K | $2.59M |
| Shares Outstanding | 4.93M | 3.38M | 22.05M | 10.52M | 6.91M | 19.00M | 18.27M | 13.36M | 246.3K | 35.64M |
| Dividends Per Share | — | — | — | — | — | $0.00 | $0.00 | $0.00 | — | — |